What this means
Type II alveolar epithelial (ATII) cells play a central role in pulmonary homeostasis, epithelial repair, and innate antiviral defense. Polyinosinic: polycytidylic acid [Poly(I: C)], a synthetic analog of viral double-stranded RNA, induces a viral-like epithelial injury phenotype characterized by oxidative stress, mitochondrial dysfunction, inflammation, and inflammasome-associated responses.
A plain-English summary is on its way. Until then, this is the start of the authors' own summary.
- Who it was tested in
- Not stated
- Kind of research
- A study
The science
- Original title
- Mitochondrial Peptide SHLP2 Limits Poly(I: C)-Induced Alveolar Epithelial Injury by Modulating Redox, Apoptotic, Inflammatory, and Inflammasome Responses.
- Authors
- Ramazan SB, Turan B, Turkkol A et al.
- Journal
- Cytotechnology
- Published
- Sep 23, 2026
- Study type
- Study
- PMID
- 42774487 ↗
Abstract
Type II alveolar epithelial (ATII) cells play a central role in pulmonary homeostasis, epithelial repair, and innate antiviral defense. Polyinosinic: polycytidylic acid [Poly(I: C)], a synthetic analog of viral double-stranded RNA, induces a viral-like epithelial injury phenotype characterized by oxidative stress, mitochondrial dysfunction, inflammation, and inflammasome-associated responses. Small humanin-like peptide 2 (SHLP2), a mitochondrial-derived peptide, has been associated with cytoprotective and mitochondrial regulatory effects; however, its role in viral-like alveolar epithelial injury remains unclear. This study investigated the effects of SHLP2 on Poly(I: C)-induced cellular damage in human ATII cells. Human ATII cells were assigned to four groups: control, SHLP2 alone, Poly(I: C) alone, and subsequent SHLP2 treatment during continued Poly(I: C) exposure. Cell viability was assessed by MTT assay. Apoptosis was evaluated by Annexin V-FITC/PI flow cytometry and by measuring BCL2/BAX expression. Mitochondrial membrane potential and intracellular reactive oxygen species (ROS) production were analyzed. Oxidative stress-related markers, inflammatory mediators and antiviral response-associated markers, and inflammasome-associated molecules were evaluated by qPCR and ELISA. In silico protein-peptide docking was performed to predict possible interactions with SHLP2. Poly(I: C) reduced cell viability and promoted apoptosis, mitochondrial depolarization, and ROS accumulation in human ATII cells. These effects were accompanied by altered BCL2/BAX expression, increased SOD2 and GPX1 expression, changes in total NRF2 and KEAP1 protein levels, elevated inflammatory mediators and Poly(I: C)-induced antiviral response-associated markers, including TNF-α, IL-6, NF-κB, TICAM1, and IFN-β, and increases in NLRP3 inflammasome-associated markers, including NLRP3, cleaved caspase-1, IL-1β, and IL-18. SHLP2 alone did not exert cytotoxic effects. Notably, subsequent SHLP2 treatment during continued Poly(I: C) exposure attenuated apoptosis, mitochondrial depolarization, ROS accumulation, inflammatory mediator production, TICAM1 and IFN-β levels, and several inflammasome-associated markers and outputs. Docking analyses predicted possible interactions of SHLP2 with TICAM1 and KEAP1, providing hypothesis-generating in silico evidence for potential associations with inflammatory and redox-related proteins. SHLP2 treatment was associated with reduced mitochondrial depolarization, oxidative stress, and apoptosis, together with changes in inflammatory and antiviral response-associated markers and NLRP3 inflammasome-related outputs in Poly(I: C)-exposed human ATII cells. These findings identify SHLP2 as an early-stage candidate for further investigation in Poly(I: C)-induced viral-like alveolar epithelial injury. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at https://doi.org/10.1007/s10616-026-01070-z.
Ramazan SB, Turan B, Turkkol A et al. Mitochondrial Peptide SHLP2 Limits Poly(I: C)-Induced Alveolar Epithelial Injury by Modulating Redox, Apoptotic, Inflammatory, and Inflammasome Responses. Cytotechnology. 2026. doi:10.1007/s10616-026-01070-z. PMID: 42774487. https://pubmed.ncbi.nlm.nih.gov/42774487/
Related research
Humanin treatment eased heart damage in diabetic mice
Mice with diabetes that got daily humanin for 15 days had less stress, inflammation, and cell death in the heart. This was tested in mice only, so it does not show the same would happen in people.
Humanin protein family may help steer cell stress responses
Researchers mapped how Humanin-related proteins connect to other proteins in a computer network. They suggest these proteins may guide stress responses, not just act alone. This is a model, so it does not show these proteins work this way in people.
Humanin, a small mitochondrial peptide, protected ovary cells from oxidative damage in lab tests
Researchers found that humanin helped human ovary cells and rat ovary tissue survive damage from oxidative stress. This was tested in cells and tissue, not people, so it does not show effects in humans.
AGEs-RAGE Axis and Mitochondrial-Derived Peptides in Advanced Chronic Kidney Disease: Interconnected Pathways Beyond Inflammation and Nutrition.
Background. Chronic kidney disease [CKD] is characterized by increased glycoxidative stress, inflammation, and mitochondrial dysfunction.
A humanin analog eased kidney damage in diabetic mice and cells
Researchers found a treated protein reduced kidney damage and cell death in diabetic mice. This work was in mice and cells, so it does not show the same effect in people.
Emerging regulators of human physiology and disease; sORF-encoded microproteins.
The human genome contains hundreds of thousands of short open reading frames (sORFs), yet their translational products, hereafter referred to as sORF-encoded microproteins (also historically termed micropeptides), have…